Correspondence 0001178913-25-000112 from Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp
Date: Jan. 14, 2025 · CIK: 0002022416 · Accession: 0001178913-25-000112
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282932
Letter
Silexion Therapeutics Corp.
12 Abba Hillel Road
Ramat Gan, Israel 5250606
January 14, 2025
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Silexion Therapeutics Corp.
Registration Statement on Form S-1
Filed January 14, 2024
File No. 333-282932
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Silexion Therapeutics Corp. (the “Company”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-282932) of the Company (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 5:15 p.m., Eastern Time, on January 15, 2025 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
SILEXION THERAPEUTICS CORP
Show Raw Text
CORRESP
1
filename1.htm
Silexion Therapeutics Corp.
12 Abba Hillel Road
Ramat Gan, Israel 5250606
January 14, 2025
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Silexion Therapeutics Corp.
Registration Statement on Form S-1
Filed January 14, 2024
File No. 333-282932
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Silexion Therapeutics Corp. (the “Company”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-282932) of the Company (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 5:15 p.m., Eastern Time, on January 15,
2025 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by
telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
SILEXION THERAPEUTICS CORP
By:
/s/ Ilan Hadar
Name:
Ilan Hadar
Title:
Chief Executive Officer
cc: Gary Emmanuel (Greenberg Traurig, LLP)